Sientra to Participate in Upcoming Investor Conferences
Sientra, a medical aesthetics company, announced management participation in three upcoming investor conferences. The events include the Stifel 2021 Healthcare Conference on November 15, featuring a fireside chat, and the Craig-Hallum Alpha Select Conference on November 16 with 1x1 meetings. Additionally, they will attend the Stephens Annual Investment Conference in Nashville, TN, on December 3, which will also include a fireside chat. Live webcasts will be available on the company's website.
- None.
- None.
SANTA BARBARA, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced that members of management are scheduled to participate in three upcoming investor conferences.
Event: Stifel 2021 Healthcare Conference (Virtual)
Format: Fireside Chat and 1x1 Meetings
Date: Monday, November 15, 2021
Presentation time: 1:20 pm ET / 10:20 am PT
Event: 12th Annual Craig-Hallum Alpha Select Conference (Virtual)
Format: 1x1 Meetings
Date: Tuesday, November 16, 2021
Event: Stephens Annual Investment Conference (In Person)
Format: Fireside Chat and 1x1 meetings at the Omni Hotel in Nashville, TN
Date: Friday, December 3, 2021
Presentation time: 1:00 pm CT / 11:00 am PT
A live and archived webcast of both the fireside chats will be available on the “Investors” section of the Sientra website at www.sientra.com.
About Sientra
Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company uniquely focused on plastic surgeons. The Company mission is to offer proprietary innovations and unparalleled partnerships that radically advance how plastic surgeons think, work and care for their patients. Sientra has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company’s Breast Products segment includes its Sientra round and shaped breast implants, the first fifth generation breast implants approved by the FDA for sale in the United States, its ground-breaking Allox2® breast tissue expander with patented dual-port and integral drain technology, and BIOCORNEUM®, the #1 performing, preferred and recommended scar gel of plastic surgeons(*).
Sientra uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Sientra is routinely posted and is accessible on the Company’s investor relations website at www.sientra.com.
(*) Data on file
Investor Relations Contact
Leigh Salvo
ir@sientra.com
FAQ
What investor conferences will Sientra attend in November 2021?
When is the Stephens Annual Investment Conference for Sientra scheduled?
How can I watch Sientra's presentations from the investor conferences?
What is Sientra's focus as a medical aesthetics company?